NRXPW vs VTRS · rev $242.0K vs rev $7.27B
NRx Pharmaceuticals Inc (NRXPW) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
NRXPW currently screens at market cap $714.6M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the NRXPW and VTRS stock pages for the full models.
Not investment advice.